| Saturday, November
3, 2007 |
6:30 AM–5:00 PM Registration
Spanish Ballroom Foyer |
Registration |
7:00 AM–8:00 AM
Spanish Ballroom Foyer |
Continental Breakfast & Poster Viewing |
8:00 AM - 9:00 AM
Spanish Ballroom |
Patient Advocacy
Moderators: Melissa Hill and Arthur Beckert |
9:00 AM–10:00 AM
Spanish Ballroom |
Session 8—Co-operative Studies
Moderators: Scott Scheutze and James Butyrnski |
| 20 |
Abstract 875 PAZOPANIB (GW786034) IN PATIENTS (PTS) WITH RELAPSED OR
REFRACTORY SOFT TISSUE SARCOMA (STS); A PHASE II STUDY FROM THE
EORTC STBSG (EORTC 62043)
*Stefan Sleijfer; Isabelle Ray-Coquard; Zsuzsa Papai; *Axel Le Cesne; Michelle Scurr; *Patrick
Schöffski; Francoise Collin; Lini Pandite; Sandrine Marreaud; Annick De brauwer; *Jean-Yves
Blay |
| 20 |
Abstract 824 ON THE DEVELOPMENT OF TARGET VOLUME GUIDELINES
IN EXTREMITY SARCOMAS; WORK IN PROGRESS BY A TRANSATLANTIC
RADIATION-ONCOLOGISTS TASK FORCE
*Rick Haas; Joop Duppen; *Brian O’Sullivan; *Thomas DeLaney; *Cecile Le Pechoux; *Patricia
Olmi; *Ronald Keus |
| 20 |
Abstract 860 A PHASE II TRIAL OF PERIFOSINE IN PATIENTS WITH CHEMOINSENSITIVE
SARCOMAS: PRELIMINARY RESULTS A SARCOMA ALLIANCE FOR
RESEARCH THROUGH COLLABORATION (SARC) STUDY
*Dejka Steinert; Craig Henderson; *Sant Chawla; Arthur Staddon; *Scott Schuetze; *Christopher
Ryan |
10:00 AM–10:30 AM
Spanish Ballroom |
Coffee Break & Poster Viewing |
10:30 AM–11:30 AM
Spanish Ballroom |
Nina Axelrad Lecture
Marc Ladanyi, M.D.
Attending Pathologist and Chief, Molecular Diagnostics Service,
Department of Pathology, and
Member, Human Oncology and Pathogenesis Program
Memorial Sloan-Kettering Cancer Center
Moderator: Doug Hawkins |
11:30 AM–12:00 PM
Spanish Ballroom |
Session 9—Fascinomas 2
Moderator: Jeremy Whelan |
| 21 |
Abstract 874 ACTIVITY AND FEASIBILITY OF TRABECTEDIN (T) AFTER REDUCED
INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN AN ADVANCED
UTERINE LEIOMYOSARCOMA PATIENT
Roberta Sanfilippo; *Federica Grosso; Elena Fumagalli; Paola Coco; Matteo Carrabba; Enrico
Civelli; Veronica Salvatori; *Jose Jimeno; Paola Allavena; Paolo Corradini; *Paolo Giovanni
Casali |
| 21 |
Abstract 849 PLEOMORPHIC RHABDOMYOSARCOMA ARISING IN A RECURRENT
GIANT CELL TUMOR OF BONE (GCT)
Cristina Smith; *Christopher Ryan; *James Hayden; *Arthur Hung; *Atiya Mansoor |
| 21 |
Abstract 843 CUTANEOUS CARCINOSARCOMA: CASE REPORT AND
COMPREHENSIVE REVIEW OF THE LITERATURE
Katy H Goldsborough; William B Laskin; *Jeffrey D Wayne; *Mark Agulnik |
12:00 PM–1:00 PM
Metropole |
Lunch |
1:00 PM– 2:30 PM
Spanish Ballroom |
Session 10—Pathology
Moderators: Andrea Deyrup and Matt van de Rihn |
| 22 |
Abstract 883 PROGNOSTIC SIGNIFICANCE OF DEDIFFERENTIATION IN
RETROPERITONEAL LIPOSARCOMA: ANALYSIS OF A LARGE SERIES TREATED
IN A SINGLE CENTRE AFTER SYSTEMATIC PATHOLOGIC REVIEW
Chiara Mussi; Paola Collini; Rosalba Miceli; Marta Barisella; Paolo Casali; Luigi Mariani; Laura
Lozza; Alessandro Gronchi |
| 22 |
Abstract 889 COMPARISON OF GENETIC, ANTIGENIC AND CLINICAL FEATURES
OF EXTRAOSSEOUS EWING SARCOMA (EO-EWS) AND OSSEOUS EWING
SARCOMA (O-EWS)
Amanda Rivera-Begeman; Carrye Cost; Charles Timmons; Patrick Leavey |
| 22 |
Abstract 892 SUPERFICIAL SARCOMA. A SERIES OF 497 CASES FROM THE
FRENCH SOFT TISSUE SARCOMA (STS) DATA BASE
*Eberhard Stoeckle; *Sylvie Bonvalot; Francoise Collin; Jean-Jacques Michels; Louis Guillou;
*Jean-Yves Blay; *Binh Bui |
| 23 |
Abstract 800 ALVEOLAR SOFT PART SARCOMA (ASPS) HAS A UNIQUE
ANGIOGENIC PROFILE AND RELATIVELY FAVORABLE CLINICAL OUTCOME
*Alexander J.F. Lazar; Das Parimal; Daniel Tuvin; Borys Korchin; Dolores Lopez-Terrada;
Raphael E. Pollock; Dina Lev |
| 23 |
Abstract 813 PROGNOSTIC VALUE OF FNCLCC GRADING, MITOTIC INDEX,
NECROSIS, AND HISTOLOGICAL SUBTYPE IN SYNOVIAL SARCOMA
Marta Barisella; *Marco Fiore; Rosalba Miceli; Paola Collini; Elisabetta Pennacchioli; *Rossella
Bertulli; *Paolo Giovanni Casali; Silvana Pilotti; *Alessandro Gronchi |
2:30 PM– 3:30 PM
Spanish Ballroom |
Session 11—Biology 1
Moderators: Junya Toguchida and Tim Damron |
| 23 |
Abstract 936 THE TYPE OF EWING ONCOPROTEIN DICTATES TUMORIGENIC AND
METASTATIC ACTIVITIES
Iranzu Gonzalez; Silvestre Vicent; Ignacio Garcia-Tunon; Susana Martinez; Carolina Zandueta;
Ana Patiño; Luis Sierrasesumaga; Mikel San Julian; Javier De Las Rivas; Enrique de Alava;
Fernando Lecanda |
| 24 |
Abstract 789 BIOLOGICAL MARKERS OF PROGNOSIS IN EWING’S SARCOMA: THE
ROLE OF GAL3BP
*Katia Scotlandi; Monia Zuntini; Diana Zambelli; Maria Cristina Manara; Stefano Iacobelli;
Antonio Llombart-Bosch; Piero Picci |
| 24 |
Abstract 870 INHIBITION OF THE MTOR AND MAPK PATHWAYS IN THE
TREATMENT OF SARCOMA
*Kathleen Mary Diehl; Qi Wu; *Laurence H Baker |
| 24 |
Abstract 775 IDENTIFICATION OF POTENTIAL CANCER STEM-LIKE CELLS IN
SYNOVIAL SARCOMA
Jefferson Terry; *Torsten O. Nielsen |
3:30 PM–4:00 PM
Spanish Ballroom |
Coffee Break & Poster Viewing |
| 25 |
Abstract 867 MOLECULAR CLASSIFICATION OF SARCOMAS WITH COMPLEX
GENETICS
Chibon Frederic; Lagarde Pauline; Coindre Jean-Michel; Aurias Alain |
| 25 |
Abstract 922 CONTRIBUTION OF CHROMOSOME BANDING AND MOLECULAR
CYTOGENETIC ANALYSES FOR THE DIAGNOSIS OF SOFT TISSUE AND BONE
TUMORS OVER A 6 YEAR PERIOD
Manuel R Teixeira; Carlos Lopes |
| 25 |
Abstract 896 USE OF GENE EXPRESSION TO IDENTIFY HETEROGENEITY OF
METASTATIC BEHAVIOR AMONG HIGH-GRADE PLEOMORPHIC SOFT TISSUE
SARCOMAS
*Keith M. Skubitz; Princy Francis; Amy P.N. Skubitz; Xianghua Luo; Mef Nilbert |
| 26 |
Abstract 948 EXT1/EXT2 GENE ANALYSIS IN TISSUES FROM SPORADIC AND
MULTIPLE OSTEOCHONDROMA, SECONDARY CHONDROSARCOMA AND
PERIPHERAL LYMPHOCYTES.
Silvia Capponcelli, Elena Pedrini, Federica Sgariglia, Alessandro Parra, Marina Mordenti, Luca
Sangiorgi |
5:00 PM–5:30 PM
Spanish Ballroom |
Conclusion of Meeting |
